Small molecule high throughput screen using AstraZeneca facilities
Summary
This UKRI funding opportunity is for researchers and companies looking to perform a high throughput screen (HTS) using AstraZeneca's extensive compound library and advanced screening robots. It aims to accelerate drug discovery by providing access to state-of-the-art facilities. The funding covers the cost of running the screen, with two opportunities available annually.
Eligibility Criteria
- Applicants must be based in the UK. - Open to academic researchers and small to medium-sized enterprises (SMEs). - Proposals can cover any target relevant to drug discovery. - No specific TRL level is mentioned, but the context implies early-stage research and development.
How to Apply
1. Visit the UKRI funding portal via the provided source URL. 2. Review the detailed guidance for the 'Small molecule high throughput screen using AstraZeneca facilities' call. 3. Prepare a proposal outlining the HTS target, methodology, and expected outcomes. Ensure alignment with AstraZeneca's compound library capabilities. 4. Submit the application through the UKRI Je-S system before the stated deadline. 5. Key documents typically include a detailed case for support, CVs of key personnel, and a cost breakdown.